Method of determining cytokine dosage for myelosuppressive state
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 26, 2006
Issued Date -
N/A
app pub date -
Jun 14, 2002
filing date -
Jan 29, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides kits and methods for evaluating the myelosuppressive state of a patient. These methods and kits provide a useful adjunct for cytotoxic and myelosuppressive therapies. By establishing threshold levels of certain cytokines as a surrogate for myelosuppression, treatment protocols can be optimized to reduce myelotoxicity, while maximizing effective dose.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully